5 results match your criteria: "US Centers for Disease Control and Prevention COVID-19 Response[Affiliation]"
Article Synopsis
- The study aimed to understand the risk factors for hospitalization due to COVID-19, focusing on both vaccinated and unvaccinated individuals to aid public health measures.
- Data was collected from over 250 hospitals between January 2021 and April 2022, comparing hospitalization rates and patient characteristics of vaccinated and unvaccinated persons with confirmed COVID-19 infections.
- Results indicated that unvaccinated individuals had significantly higher hospitalization rates—up to 17.7 times higher compared to vaccinated individuals—particularly during the Omicron variant surge.
Article Synopsis
- * A study used data from nearly 75,000 tests involving children and adolescents to assess the vaccine's effectiveness during the Omicron surge by comparing vaccinated individuals to those unvaccinated.
- * The analysis included significant sample sizes, revealing important insights into the relationship between prior vaccination and the occurrence of symptomatic COVID-19 infections among youth during a key period.
Importance: Multiple inflammatory syndrome in children (MIS-C) occurs in association with the COVID-19 pandemic.
Objective: To describe the clinical characteristics and geographic and temporal distribution of the largest cohort of patients with MIS-C in the United States to date.
Design, Setting, And Participants: Cross-sectional analysis was conducted on clinical and laboratory data collected from patients with MIS-C.
Changes in Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Over Time in 10 Sites in the United States, March-August, 2020.
Clin Infect Dis
November 2021
US Centers for Disease Control and Prevention COVID-19 Response Team, Atlanta, Georgia, USA.
Background: Monitoring of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody prevalence can complement case reporting to inform more accurate estimates of SARS-CoV-2 infection burden, but few studies have undertaken repeated sampling over time on a broad geographic scale.
Methods: We performed serologic testing on a convenience sample of residual serum obtained from persons of all ages, at 10 sites in the United States from 23 March through 14 August 2020, from routine clinical testing at commercial laboratories. We standardized our seroprevalence rates by age and sex, using census population projections and adjusted for laboratory assay performance.
US Hydroxychloroquine, Chloroquine, and Azithromycin Outpatient Prescription Trends, October 2019 Through March 2020.
JAMA Intern Med
October 2020
US Centers for Disease Control and Prevention COVID-19 Response Team, National Center for Emerging and Zoonotic Infectious Diseases, Division of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, Georgia.
This study examines how the prescription of hydroxychloroquine and chloroquine to outpatients has changed in the United States during the coronavirus disease 2019 pandemic.
View Article and Find Full Text PDF